D
David S. Menaldino
Researcher at Emory University
Publications - 27
Citations - 1124
David S. Menaldino is an academic researcher from Emory University. The author has contributed to research in topics: Allosteric regulation & Receptor. The author has an hindex of 14, co-authored 27 publications receiving 1030 citations.
Papers
More filters
Journal ArticleDOI
Structural requirements for long-chain (sphingoid) base inhibition of protein kinase C in vitro and for the cellular effects of these compounds
Alfred H. Merrill,Sanjay Nimkar,David S. Menaldino,Yusuf A. Hannun,Carson R. Loomis,Robert M. Bell,Shiv Raj Tyagi,J. David Lambeth,Victoria L. Stevens +8 more
TL;DR: The findings establish that the major structural features required for inhibition of protein kinase C and cellular processes dependent on this enzyme are the presence of a free amino group and an aliphatic side chain and that other groups have more subtle effects.
Journal ArticleDOI
Acylation of naturally occurring and synthetic 1-deoxysphinganines by ceramide synthase. Formation of N-palmitoyl-aminopentol produces a toxic metabolite of hydrolyzed fumonisin, AP1, and a new category of ceramide synthase inhibitor.
Hans-Ulrich Humpf,Eva-Maria Schmelz,Filmore I. Meredith,Hubert W. Vesper,Teresa R. Vales,Elaine Wang,David S. Menaldino,Dennis C. Liotta,Alfred H. Merrill +8 more
TL;DR: The studies demonstrate that the 1-hydroxyl group is not required for sphingoid bases to be acylated; both erythro- andthreo-isomers are acylation with the highest apparent V max/K m for theerythro -analogs; and AP1 is acylations to PAP1, a new category of ceramide synthase inhibitor as well as a toxic metabolite that may play a role in the diseases caused by fum
Journal ArticleDOI
A stereoselective synthesis of sphingosine, a protein kinase c inhibitor
TL;DR: A stereoselective synthesis of each of the four enantiomers of sphingosine from either L- or D-serine is reported, and the key steps involve the diastereoselectives addition of 1-lithiopentadecyne to aldehyde 4 and Mitsunobu inversion of propargyl alcohol 5.
Journal ArticleDOI
Sphingoid bases and de novo ceramide synthesis: enzymes involved, pharmacology and mechanisms of action
David S. Menaldino,Anatoliy S. Bushnev,Aiming Sun,Dennis C. Liotta,Holly Symolon,Kena Desai,Dirck L. Dillehay,Qiong Peng,Elaine Wang,Jeremy C. Allegood,Sarah Trotman-Pruett,M. Cameron Sullards,Alfred H. Merrill +12 more
TL;DR: Methods for the preparation of libraries of sphingoid bases, including a series of 1-deoxy-analogs, as well as information about their metabolism and biological activities are described.
Book ChapterDOI
Fumonisin toxicity and sphingolipid biosynthesis
Alfred H. Merrill,Elaine Wang,Teresa R. Vales,Elizabeth R. Smith,Joseph J. Schroeder,David S. Menaldino,Christopher W. Alexander,H. M. Crane,J. Xia,Dennis C. Liotta,Filmore I. Meredith,Ronald T. Riley +11 more
TL;DR: Studies with diverse types of cells have established that fumonisin B1 not only blocks the biosynthesis of complex sphingolipids; but also, causes sphinganine to accumulate, which may account for the toxicity, and perhaps the carcinogenicity, offumonisins.